Linkedin X-twitter Youtube
Launch Digital Edition

Webinars and Sponsored Roundtables — Register Now

Wednesday, August 26, 2026 1 PM-2 PM ET
Learn about digital pathology technology that is future-ready, yet practical for today’s
laboratory needs.

Webinar presenters Scott Hammond, Senior Systems Consultant, Digital Pathology Division, Wexner Medical Center, Department of Pathology, and Ursula Hofer, Imaging Technologist, Pathology Digital Imaging Lab, Wexner Medical Center, Department of Pathology, and Sandra Banky, PA(ASCP), Director of Operations, Wexner Medical Center, Department of Pathology, and Molly Epler, MHI, LSSYB, Clinical Laboratory Manager, Wexner Medical Center.

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

Register Now

Wednesday, September 23, 2026. 12 PM-12:30 PM ET
Roundtable presenters Dr. David Sacks MB, ChB, FRCPath, Chairman, Steering Committee National Glycohemoglobin Standardization Program (NGSP), and Priya Sivaraman, PhD, Senior Technical Product Manager, Tosoh Bioscience.

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

Register Now

Wednesday, September 30, 2026. 1 PM-1:30 PM ET
Roundtable presenters John Longshore, PhD, Head of Scientific Affairs, Global Oncology Diagnostics, AstraZeneca, and Flora Berisha, MS, Executive Director, Global Head of Diagnostic Partnering and Development, Johnson & Johnson Innovative Medicine, and Mark D. Ewalt, MD, Associate Medical Director for Laboratory Operations, Diagnostic Molecular Pathology, Molecular Diagnostics Service, Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, and Isabel Preeshagul, DO, MBS, Thoracic Medical Oncologist, Memorial Sloan Kettering Cancer Center.

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

Register Now

Subspecialties

Interactive Product Guides

All Issues

Clinical pathology selected abstracts

August 2026—Patients undergoing cardiac surgery have a higher risk of excessive bleeding and complications due to dilutional effects during surgery and activation and consumption of platelets and coagulation factors. Increasing recognition of the related morbidity and mortality has heightened interest in patient blood management, including autologous blood salvage (ABS) using an automated cell-salvage system for safe and effective blood conservation in cardiac surgery with cardiopulmonary bypass. Of importance in adult and pediatric populations is that reinfused washed red blood cells be of high quality to prevent adverse events from cytolysis and activation processes and severe and fatal complications.

Anatomic pathology selected abstracts

August 2026—Primary perianal adenocarcinoma of intestinal type has been described in recent literature and proposed as a subtype of extramucosal anal adenocarcinoma. Whether this represents a unique entity remains to be elucidated. The authors conducted a study in which they analyzed the clinicopathologic and genomic features of 14 cases of primary perianal adenocarcinoma of intestinal type (PPAI).

Molecular pathology selected abstracts

August 2026—Kawasaki disease is an acute vasculitis of childhood and the most common cause of acquired heart disease in children worldwide. Up to 25 percent of untreated patients develop coronary artery aneurysms. The variable clinical presentation of Kawasaki disease (KD) complicates diagnosis, treatment, and understanding of the disease and highlights the need for molecular tools to stratify patients into biologically meaningful subgroups.

Q&A column

August 2026
Q. Are laboratories sticking to the established standard of spinning whole blood coagulation test tubes within four hours of specimen collection or are most changing to a 24-hour window (with some exceptions) per Clinical and Laboratory Standards Institute guidelines? Read answer.
Q. I am evaluating a large, well-circumscribed necrotic pelvic peritoneal implant in a case of serous borderline tumor (SBT) of the ovary. The implant shows nonviable necrotic tissue displaying only residual ghost papillary outlines with calcification. My initial interpretation is the peritoneal nodule is an invasive implant because it is large. I am assuming the necrosis represents infiltrative, destructive, and expansile neoplastic cells that form the large nodule (17 mm). I considered upgrading the SBT to low-grade serous carcinoma (LGSC) because of the presence of this implant. However, since the implant is necrotic, I cannot reliably evaluate for tumor cells. In addition, it is rare to have an invasive implant without an invasive component at the primary site. What is your opinion regarding this implant? Read answer.

Newsbytes

August 2026—Pathologists and other cross-departmental staff at Beth Israel Lahey Health, in Boston, recently used an “all for one and one for all” approach to decision-making in evaluating image-management systems for purchase.

Put It on the Board

August 2026—Roche in June launched its Axelios 1, a next-generation single-molecule sequencing platform that it says will address bottlenecks in genomics and potentially in clinical research.

Shorts on Standards

August 2026—The CAP introduced in its 2025 accreditation checklist edition GEN.20315 Risk Management, which says the laboratory’s quality management system uses a prospective risk management process. That process includes identification, control, and monitoring of risks throughout the laboratory.

Time to improve preeclampsia screening

July 2026—Among its many peculiarities, medicine dwells in interstitial spaces—between seeing a problem and addressing it; between the (in)actions of one specialty and another; between practice and practice guidelines; between overtreatment and targeted treatment; between widespread access and boutique care.

Hematopathology’s move to the Fellowship Match

July 2026—When Neha Gupta, MD, attended a fellowship fair early in her second year of residency, she was caught off guard by the number of programs already accepting applications from her peers. It was only March, and she had been told she could apply for her fellowship in late summer.

Assessing neoadjuvant therapy response in lung resection specimens

July 2026—An International Association for the Study of Lung Cancer panel provided recommendations in 2020 on how to process lung cancer resection specimens and define pathologic response after neoadjuvant therapy. They were intended as guidance for clinical trials but offered as a suggestion for good clinical practice.

MARKETPLACE

TRENDING